Directorate Change

Smiths Group PLC
24 April 2007

Smiths appoints new non-executive director

24/04/2007

Smiths Group plc announces the appointment of Peter Loescher as a non-executive
director with effect from 1 June 2007.



Peter Loescher is President, Global Human Health, Merck & Company Inc. An
Austrian based in the USA, Peter is a veteran of the healthcare industry having
been President and CEO of GE Healthcare Bio-Sciences (and a member of the GE
Corporate Executive Council), and before that Chief Operating Officer of
Amersham plc, prior to his appointment at Merck in May 2006.



Before joining Amersham in 2002, he spent more than 16 years with Aventis and
Hoechst, based in the US, UK, Japan, Germany and Spain. He is an MBA graduate of
the Vienna University School of Economics and also studied at the Chinese
University of Hong Kong and Harvard Business School.



Donald Brydon, Chairman, Smiths Group plc said: 'I am delighted that Peter has
agreed to join the Board of Smiths.  He brings a strong track record in the
healthcare industry and a deep understanding of the global business environment
in which Smiths operates.'



Other than his previous appointment as a director of Amersham plc when it was a
publicly-quoted company, there is no information concerning Peter Loescher which
requires disclosure under Rule LR 9.6.13 R of the UK Listing Authority Listing
Rules.

Smiths Group
Smiths is a global technology company, listed on the London Stock Exchange.
Smiths Group is a world leader in the practical application of advanced
technologies.  Its products and services make the world safer, healthier and
more productive. Smiths Group has four divisions: Aerospace, Detection, Medical
and Specialty Engineering. It employs 32,000 people and has over 250 major
facilities in 50 countries. On 15 January 2007 Smiths Group announced the sale
of Smiths Aerospace to GE which remains subject to regulatory approval. For more
information visit www.smiths.com



Investor Relations           Media
Russell Plumley               Chris Fox
[phone]      [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange